TP63, member of TP53 family of tumor suppressor genes and largely described with importance in vulvar cancer, was identified as a target for miR-223-5p in three prediction algorithms and thus, further explored as a target for miR-223-5p in vitro and in relation to patient's clinicopathological features. The gene discussed is TP53; the disease is vulva cancer.